MOREADITH RANDALL (Chief Scientific Officer) sold 6.50K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.3K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/14/2026ACC: 0001301120-26-000004
Officer· Chief Scientific Officer
Since Feb 2026
-6.50K
Net shares
Net seller
$16.3K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
6.50K acquired · 13K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5.42K
Price / share
$0.06
Trade value
$324.96
% of position
New position
1/13/2026
0.00→5.42K
Common Stock
Direct
Shares
−5.42K
Price / share
$2.50
Trade value
$13.54K
% of position
New position
1/13/2026
5.42K→0.00
Common Stock
Direct
Shares
+1.08K
Price / share
$0.06
Trade value
$65.04
% of position
New position
1/14/2026
0.00→1.08K
Common Stock
Direct
Shares
−1.08K
Price / share
$2.50
Trade value
$2.71K
% of position
New position
1/14/2026
1.08K→0.00
Total
Net shares
+0.00
Net value
-$15.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2026 | M · Option Exercise | +5.42K | $0.06 | $324.96 | New position | 0.00 | 5.42K |
| Common Stock Direct | 1/13/2026 | S · Sale | −5.42K | $2.50 | $13.54K | New position | 5.42K | 0.00 |
| Common Stock Direct | 1/14/2026 | M · Option Exercise | +1.08K | $0.06 | $65.04 | New position | 0.00 | 1.08K |
| Common Stock Direct | 1/14/2026 | S · Sale | −1.08K | $2.50 | $2.71K | New position | 1.08K | 0.00 |
| Total | +0.00 | -$15.86K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
5.42K shares
Shares
−5.42K
Strike price
0.06
Held after
333.77K
Exercisable
—
1/13/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.08K shares
Shares
−1.08K
Strike price
0.06
Held after
332.69K
Exercisable
—
1/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock5.42K shares | 1/13/2026 | M · Option Exercise | −5.42K | 0.06 | — | 333.77K |
| Stock Option (right to buy) Direct | Common Stock1.08K shares | 1/14/2026 | M · Option Exercise | −1.08K | 0.06 | — | 332.69K |